2
Clinical Trials associated with Fosinopril Sodium/Hydrochlorothiazide / CompletedNot Applicable A Bioequivalence Study of Test and Reference Fosinopril Sodium/ Hydrochlorothiazide 20/12.5 mg Tablets Under Fasting Conditions
The objective of this study was to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets by Ranbaxy Laboratories Limited with that of Monopril ®.-HCT 20-12.5 mg tablets by Bristol-Meyers Squibb following a single oral dose (1 x 20-12.5 mg tablet) in healthy adult subjects under fasting conditions
/ CompletedNot Applicable A Bioequivalence Study of Test and Reference Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Non-Fasting Conditions
The objective of this study is to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets of Ranbaxy laboratories Limited with that of Monopril ® - HCT 20-12.5 mg tablets by Bristol Meyers Squibb following a single oral dose (1 x 20/12.5 mg tablet) in healthy adult subjects under non-fasting conditions.
100 Clinical Results associated with Fosinopril Sodium/Hydrochlorothiazide
100 Translational Medicine associated with Fosinopril Sodium/Hydrochlorothiazide
100 Patents (Medical) associated with Fosinopril Sodium/Hydrochlorothiazide
100 Deals associated with Fosinopril Sodium/Hydrochlorothiazide